Marque R. Dietzler, PA

Marque Dietzler practices at Fresno Specialty Surgery Center, PC in Fresno, California.

Marque Dietzler's NPI, 1073968459, was assigned on May 4, 2016.

Marque Dietzler's primary practice is Fresno Specialty Surgery Center, PC, at 6181 N Thesta St, Fresno, CA 93710 in Fresno County. The practice phone is (800) 991-6448.

Marque Dietzler's primary practice is Fresno Specialty Surgery Center, PC in Fresno, California. Marque Dietzler is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Marque Dietzler to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Marque Dietzler practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Marque Dietzler's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and minor head injury among the conditions Marque Dietzler treats.

CMS data shows 2,879 Medicare services from Marque Dietzler across 17 procedure codes in 2024, for 289 Medicare patients. Medicare paid $105,820 for them. Every service was in an office.

CMS counts 289 Medicare patients who saw Marque Dietzler in 2024. The largest group is 65 to 74, with 158 patients. 70% of them have high cholesterol, and 58% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Marque Dietzler's median patient age at 46, with 63% women.

In 2024, Marque Dietzler wrote 695 Medicare Part D claims for 235 patients. 89% of them were for generic drugs. CMS names the drug for 403 of them, across 18 drugs with 11 or more claims each, at $81,823 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Marque Dietzler for performance year 2024, reported as part of a group. Marque Dietzler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 60 general payments to Marque Dietzler from 19 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 83% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $253.